Biofrontera Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BFRI Nasdaq 3840 www.biofrontera-us.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biofrontera Inc.

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference - Dec 3rd, 2024 4:00 pm
Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note - Nov 22nd, 2024 2:10 pm
Biofrontera Inc (BFRI) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst Revenue ... - Nov 15th, 2024 7:12 am
Biofrontera Inc. (BFRI) Reports Q3 Loss, Lags Revenue Estimates - Nov 14th, 2024 12:10 am
Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update - Nov 13th, 2024 10:15 pm
Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024 - Nov 1st, 2024 4:55 pm
Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) - Oct 31st, 2024 2:32 pm
Rosalind Advisors, Inc. Reduces Stake in Biofrontera Inc - Oct 23rd, 2024 11:01 pm
Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC) - Oct 14th, 2024 2:30 pm
Biofrontera Inc (BFRI) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Oct 9th, 2024 10:29 pm
FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment - Oct 7th, 2024 12:45 pm
Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference - Sep 25th, 2024 2:45 pm
Biofrontera Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Aug 17th, 2024 12:35 pm
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update - Aug 14th, 2024 8:30 pm
Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024 - Aug 9th, 2024 2:00 pm
When Will Biofrontera Inc. (NASDAQ:BFRI) Become Profitable? - Jul 12th, 2024 10:58 am
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp - Jun 24th, 2024 12:30 pm
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update - May 15th, 2024 8:45 pm
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024 - May 6th, 2024 2:30 pm
Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants - May 3rd, 2024 12:50 pm